Freda Biopharm was established in 1998 by Shandong Freda Pharmaceutical Group Corporation and Tactful World Limited(Hong Kong). The company is focusing on R&D, production and sales of hyaluronic acid and related products. Hyaluronic acid products of cosmetic, food, eye drop and injection (API) grades are manufactured for different applications and requirements of customers.

The Company has passed international quality certification for ISO 9001 and ISO 13485, and is managed strictly in accordance with the quality system to ensure the reliability and stability of product quality. An application has been made for a DMF registration number from FDA for Injection Grade of Hyaluronic acid, and the quality meets the standards of both European Pharmacopoeia and Japanese Pharmacopoeia. The company has become the largest manufacturer of hyaluronic acid in the world with 30 tons of annual output. It has gained more than 70% of the domestic market share, and its products are exported to the U.S., Japan, the EU and other counties and areas. The company is global hyaluronic acid supplier for world famous producers of health foods, cosmetics and pharmaceuticals.